These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 15202319

  • 1. [Nitric oxide--a potential modulator of left ventricular diastolic function in hemodialysis patients treated with erythropoietin].
    Rasić S, Kulenović I, Zulić I, Huskić J, Avdagić N, Babić N, Uncanin S, Haracić A.
    Med Arh; 2004; 58(2):109-12. PubMed ID: 15202319
    [Abstract] [Full Text] [Related]

  • 2. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters.
    Kirkpantur A, Kahraman S, Yilmaz R, Arici M, Altun B, Erdem Y, Yasavul U, Turgan C.
    Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652
    [Abstract] [Full Text] [Related]

  • 3. [Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end-stage renal failure: impact of long-term erythropoietin therapy].
    Dzgoeva FU, Gatagonova TM, Kadzaeva ZK, Khamitsaeva OV, Kochisova ZKh, Dzueva AT, Bazaeva BG, Bestaeva TL.
    Ter Arkh; 2013 Dec; 85(6):44-50. PubMed ID: 23866598
    [Abstract] [Full Text] [Related]

  • 4. [Improvement of left ventricular hypertrophy by anemic-correcting erythropoietin therapy in chronic renal insufficiency].
    Jiang JP, Hou FF, Gao LZ, Pan YB, Yang NS, Chen W, Shu GY, Chen YM, Chen J, Peng WH, Wu JP, Yang ZM.
    Zhonghua Nei Ke Za Zhi; 2005 Jan; 44(1):25-9. PubMed ID: 15769393
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of left ventricular diastolic function in nonhypertensive nondiabetic hemodialysis patients.
    Karavelioğlu Y, Özkurt S, Karapinar H, Küçükdurmaz Z, Arisoy A, Kurt R, Yilmaz A, Yarlioglues M, Akpek M, Kaya MG.
    Blood Press Monit; 2013 Oct; 18(5):239-46. PubMed ID: 24013617
    [Abstract] [Full Text] [Related]

  • 8. [Angiotensin converting enzyme and left ventricular hypertrophy in uremic patients: correlation and therapeutic options].
    Rasić S, Catović A, Huskić J, Haracić A, Babić N, Avdagić N, Uncanin S.
    Acta Med Croatica; 2004 Oct; 58(3):193-6. PubMed ID: 15503682
    [Abstract] [Full Text] [Related]

  • 9. The effect of erythropoietin treatment on left ventricular hypertrophy in haemodialysis patients.
    Rasić S, Kulenović I, Zulić I, Haracić A, Cengić M, Uncanin S, Dzemidzić J.
    Bosn J Basic Med Sci; 2003 Nov; 3(4):11-5. PubMed ID: 16232131
    [Abstract] [Full Text] [Related]

  • 10. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study.
    Pascual J, Teruel JL, Moya JL, Liaño F, Jiménez-Mena M, Ortuño J.
    Clin Nephrol; 1991 Jun; 35(6):280-7. PubMed ID: 1831414
    [Abstract] [Full Text] [Related]

  • 11. Changes in left ventricular mass and filling after renal transplantation are related to changes in blood pressure: an echocardiographic and pulsed Doppler study.
    Peteiro J, Alvarez N, Calviño R, Penas M, Ribera F, Castro Beiras A.
    Cardiology; 1994 Jun; 85(5):273-83. PubMed ID: 7850816
    [Abstract] [Full Text] [Related]

  • 12. [Correlations between blood pressure, left ventricular hypertrophy, and left ventricular diastolic function in hypertensive patients].
    Ito O, Okamoto M, Murakami Y, Nakayama R.
    J Cardiol; 1991 Jun; 21(4):931-41. PubMed ID: 1844449
    [Abstract] [Full Text] [Related]

  • 13. Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia.
    Thanakitcharu P, Siriwiwatanakul N.
    J Med Assoc Thai; 2007 Dec; 90(12):2574-86. PubMed ID: 18386706
    [Abstract] [Full Text] [Related]

  • 14. [Doppler tissue imaging: a new method in the study of diastolic function in left ventricular hypertrophy].
    Vezù L, Bilardo G, Collet L, Noventa F, Delise P.
    G Ital Cardiol; 1999 Jan; 29(1):63-71. PubMed ID: 9987050
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Impact of left ventricular patterns and diastolic dysfunction on hemodialysis patients].
    Gagliardi GM, Rossi S, Manes MT, Gerace G, Martire V, Caruso F, Vocaturo G, De Napoli N.
    G Ital Nefrol; 2004 Jan; 21(1):45-50. PubMed ID: 15356847
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The cardiovascular and hemodynamic effects of erythropoietin in chronic renal failure.
    Singh NP, Chandrashekhar, Nair M, Anuradha S, Kohli R, Agarwal SK.
    J Assoc Physicians India; 2000 Mar; 48(3):301-6. PubMed ID: 11229114
    [Abstract] [Full Text] [Related]

  • 19. Influence of left ventricular hypertrophy on the diastolic performance in hypertensive patients and in athletes.
    Lefkos N, Boudonas G, Vassilicos V, Efthymiadis A.
    Acta Cardiol; 1993 Mar; 48(5):507-14. PubMed ID: 8284991
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.